OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 02, 2022
Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.
April 27, 2022
GeoVax has received a patent for its malaria vaccine from the US Patent and Trademark Office.
April 21, 2022
The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.
April 14, 2022
ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.
April 11, 2022
IAVI and Moderna have announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health issues.
April 07, 2022
Catalent has acquired the Vaccine Manufacturing Innovation Centre in Harwell, Oxford to expand its biologics capabilities across the UK and Europe.
April 06, 2022
Merck has expanded its manufacturing facility in Elkton, Va. to further increase its HPV vaccine supply.
April 05, 2022
UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.
March 31, 2022
KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.
March 25, 2022
Pfizer’s respiratory syncytial virus vaccine candidate has received Breakthrough Therapy Designation from FDA for the prevention of RS in older adults.